US Bancorp
- SEC CIK
- 0000036104
- Latest filing
- Aug 12, 2026
GRTX holding history
Galera Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GRTX overviewAll 13F holders of GRTXFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −3,000−100.0% | Sold out | Holders |
| Q1 2024 | 3,000 | $420 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 3,000 | $436 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 3,000 | $525 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 3,000 | $9.36K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 3,000 | $7.68K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 3,000 | $4.47K | <0.1% | −383−11.3% | Reduced | Holders |
| Q3 2022 | 3,383 | $6.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 3,383 | $4.00K | <0.1% | +2,000+144.6% | Added | Holders |
| Q1 2022 | 1,383 | $3.00K | <0.1% | −9,579−87.4% | Reduced | Holders |
| Q4 2021 | 10,962 | $51.0K | <0.1% | +383+3.6% | Added | Holders |
| Q3 2021 | 10,579 | $86.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 10,579 | $104.0K | <0.1% | +10,579 | New | Holders |